- Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel Loading Dose; Drug: Prasugrel Maintenance Dose; Drug: Ticagrelor Maintenance Dose
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Eli Lilly and Company
Recruiting - verified April 2012 - Conditions: Advanced Solid Tumor; Lymphoma
Intervention: Drug: DS-3078a
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified April 2012 - Conditions: Percutaneous Coronary Intervention; Dual Antiplatelet Therapy; Aspirin; Clopidogrel
Intervention:
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; Daiichi Sankyo Inc.; Accumetrics, Inc.
Recruiting - verified April 2012 - Condition: Hypercholesterolemia With Concomitant Type 2 Diabetes
Interventions: Drug: Atorvastatin; Drug: Rosuvastatin
Sponsors: Listen Trial Group; Listen Trial Group
Recruiting - verified April 2012 - Conditions: Hypertension; Chronic Kidney Disease; Microalbuminuria
Intervention: Behavioral: Intensive education for low salt diet
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital; Daiichi Sankyo Inc.; Daewoong Pharmaceutical Co. LTD.
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Modification of Prasugrel based on a biological assay; Drug: prasugrel / clopidogrel; Device: Verify Now
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Eli Lilly and Company; Daiichi Sankyo Inc.; Allies in Cardiovascular Trials Initiatives and Organized Networks:ACTION; Accumetrics, Inc.; Stentys
Not yet recruiting - verified February 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: U3-1287; Drug: Trastuzumab; Drug: Paclitaxel; Drug: U3-1287; Drug: Trastuzumab; Drug: Paclitaxel; Drug: Placebo
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; ACTIVA
Recruiting - verified January 2012 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Conditions: Pain; Diabetic Peripheral Neuropathy
Interventions: Drug: DS-5565; Drug: DS-5565; Drug: DS-5565; Drug: Placebo; Drug: Pregabalin capsules
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Co., Ltd.
Recruiting - verified February 2012 - Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: DS-5565 tablet; Drug: pregabalin capsule; Drug: Placebo
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified March 2012 - Conditions: Solid Tumors; Lymphoma; Multiple Myeloma
Intervention: Drug: CS-7017 and Bexarotene
Sponsors: Georgetown University; Georgetown University; Daiichi Sankyo Inc.
Recruiting - verified December 2011 - Condition: Sickle Cell Disease
Intervention: Drug: Prasugrel
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Daiichi Sankyo Inc.
Recruiting - verified April 2012 - Conditions: Aspergillosis, Aspergilloma; Candidemia, Candidiasis; Cryptococcal Meningitis, Pulmonary Cryptococcosis; Fusariosis; Scedosporiosis
Interventions: Drug: Voriconazole; Drug: Voriconazole
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Solid Tumor; Colorectal Cancer; Endometrial Cancer
Intervention: Drug: DS-7423
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified March 2012
 |
Daiichi Sankyo - Database of Clinical Trials by Pharmaceutical Companies |
